V. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS PRELIMINARY PROGRAM
- How Should We Treat Hodgking Lymphoma?
Hodgkin's Lymphoma : Diagnosis and Staging
First-line Therapy ,Evaluation of Response and Second line Therapy
- How Should We Treat MDS?
Myelodysplastic Syndromes : Old and New Classifications and Prognostic Scores
Therapy of MDS
New Drugs in MDS
Essential Therapeutic Approach to the MDS Patient
Special Lecture: Iron Overload and MDS
- The Future : New Targets for the Therapy of Hematological Malignancies
New Targets in ALL
New Targets in AML : Only for Minimal Residual Disease?
New Targets in MPNs
New Indications for Old Antibodies : HUS . PNH Disease Model
- Infections in Hematology
IFI Management : Putting Theory into Pratice
New Antibiotic Strategy in Neutropenia
Profilactic Anti Fungal Treatment in Hematologic Malignancies
- How to manage Myeloid and Lymphoid Chronic Leukemias and MPNs
Chronic Lymphocytic Leukemia : Essential Steps for a Correct Risk Stratification
CLL : Old and New Therapies
CML : How Do We Have to Treat our CML Patients in the era of Genetic Imatinib?
Steps Towards Treatment Discontinuation : Why , in Which Patients , When and How
MPNs : What's Really New in the Classification , Prognosis and Therapy?
How I Manage PV
- How to manage Acute Leukemias
The Essential Management of AML
The Essential Management of Adult ALL
Present and Future of Ph-Positive ALL Treatment
Which Acute Leukemia Patients and When to be Referred to Transplant Centers?
- How to treat Multiple Myeloma
Multiple Myeloma : Which is the Best and Most Convenient during the First-line Therapy?
Management of Relapses and Refractory Cases
Optimizing Treatment of MM Complications
New Drugs in MM
- Stem Cell Transplant
What is Essential to Know About Stem Cells
The Autologous Transplant : Essential Indication
Advances in Mobilization Failure
Haploidentical Stem Cell Transplant
Cord Blood Transplant : a Reliable Alternative for Elderly Patients?
- Non Hodgkin Lymphoma
How I Manage Indolent Non-HL
How I Manage Mantle Cell Lymphoma
How I Manage DLBCLs Cell Lymphoma
How I manage peripheric T-cell Lymphomas
Is MRD Detection Really Needed for Lymphoproliferative Treatment?
-Next Generation Micro-analysis and Diagnosis using Computational Imaging, Crowdsourcing
and Gaming